Abstract
Aims/hypothesis: The hormone glucagon-like peptide 1 (GLP-1) is released in response to a meal from the intestinal L-cells, where it is processed from proglucagon by the proconvertase (PC)1/3. In contrast, in the adult islets proglucagon is processed to glucagon by the PC2 enzyme. The aim of the study was to evaluate if, during the development of diabetes, alpha cells produce GLP-1 that, in turn, might trigger beta cell growth. Methods: Beta cell mass, GLP-1 and insulin levels were measured in the gerbil Psammomys obesus (P. obesus), a rodent model of nutritionally induced diabetes. Furthermore, the presence of biologically active forms of GLP-1 and PC1/3 in alpha cells was demonstrated by immunofluorescence,and the release of GLP-1 from isolated P. obesus, mouse and human islets was investigated. Results: During the development of diabetes in P. obesus, a significant increase in GLP-1 was detected in the portal vein (9.8±1.5 vs 4.3±0.7 pmol/l, p<0.05), and in pancreas extracts (11.4±2.2 vs 5.1±1.3 pmol/g tissue, p<0.05). Freshly isolated islets from hyperglycaemic animals released more GLP-1 following 24 h culture than islets from control animals (28.2±4.4 pmol/l vs 5.8±2.4, p<0.01). GLP-1 release was increased from healthy P. obesus islets following culture in high glucose for 6 days (91±9.1 pmol/l vs 28.8±6.6, p<0.01). High levels of GLP-1 were also found to be released from human islets. PC1/3 colocalised weakly with alpha cells. Conclusions/interpretation: GLP-1 release from alpha cells is upregulated in P. obesus during the development of diabetes. A similar response is seen in islets exposed to high glucose, which supports the hypothesis that GLP-1 released from alpha cells promotes an increase in beta cell mass and function during metabolic challenge such as diabetes.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetologia |
Vol/bind | 54 |
Udgave nummer | 6 |
Sider (fra-til) | 1379-87 |
Antal sider | 9 |
ISSN | 0012-186X |
DOI | |
Status | Udgivet - jun. 2011 |